These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10788488)

  • 21. Downregulation of doxorubicin-induced myocardial apoptosis accompanies postnatal heart maturation.
    Shi J; Zhang L; Zhang YW; Surma M; Mark Payne R; Wei L
    Am J Physiol Heart Circ Physiol; 2012 Apr; 302(8):H1603-13. PubMed ID: 22328080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zinc-induced metallothionein overexpression prevents doxorubicin toxicity in cardiomyocytes by regulating the peroxiredoxins.
    Jing L; Li L; Zhao J; Zhao J; Sun Z; Peng S
    Xenobiotica; 2016 Aug; 46(8):715-25. PubMed ID: 26599915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
    Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
    Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metallothionein prevents doxorubicin cardiac toxicity by indirectly regulating the uncoupling proteins 2.
    Jing L; Yang M; Li Y; Yu Y; Liang B; Cao L; Zhou X; Peng S; Sun Z
    Food Chem Toxicol; 2017 Dec; 110():204-213. PubMed ID: 29061315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serine mutations in overexpressed Hsp27 abrogate the protection against doxorubicin-induced p53-dependent cardiac apoptosis in mice.
    Kanagasabai R; Karthikeyan K; Zweier JL; Ilangovan G
    Am J Physiol Heart Circ Physiol; 2021 Nov; 321(5):H963-H975. PubMed ID: 34477462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    El-Said NT; Mohamed EA; Taha RA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Nrdp1 in the heart exacerbates doxorubicin-induced cardiac dysfunction in mice.
    Zhang Y; Kang YM; Tian C; Zeng Y; Jia LX; Ma X; Du J; Li HH
    PLoS One; 2011; 6(6):e21104. PubMed ID: 21738612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-induced cardiotoxicity involves IFNγ-mediated metabolic reprogramming in cardiomyocytes.
    Ni C; Ma P; Wang R; Lou X; Liu X; Qin Y; Xue R; Blasig I; Erben U; Qin Z
    J Pathol; 2019 Mar; 247(3):320-332. PubMed ID: 30426505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways.
    Aihara Y; Kurabayashi M; Tanaka T; Takeda SI; Tomaru K; Sekiguchi KI; Ohyama Y; Nagai R
    J Mol Cell Cardiol; 2000 Aug; 32(8):1401-14. PubMed ID: 10900167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide.
    Kang YJ; Zhou ZX; Wu H; Wang GW; Saari JT; Klein JB
    Lab Invest; 2000 May; 80(5):745-57. PubMed ID: 10830785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxorubicin induces slow ceramide accumulation and late apoptosis in cultured adult rat ventricular myocytes.
    Delpy E; Hatem SN; Andrieu N; de Vaumas C; Henaff M; Rücker-Martin C; Jaffrézou JP; Laurent G; Levade T; Mercadier JJ
    Cardiovasc Res; 1999 Aug; 43(2):398-407. PubMed ID: 10536670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metallothionein inhibited DOX-induced cardiac apoptosis in mice].
    Shuai Y; Guo J; Peng SQ; Zhang LS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):620-3. PubMed ID: 17718425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant and anti-apoptotic effects of onion (Allium cepa) extract on doxorubicin-induced cardiotoxicity in rats.
    Alpsoy S; Aktas C; Uygur R; Topcu B; Kanter M; Erboga M; Karakaya O; Gedikbasi A
    J Appl Toxicol; 2013 Mar; 33(3):202-8. PubMed ID: 21996788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan oligosaccharides prevent doxorubicin-induced oxidative stress and cardiac apoptosis through activating p38 and JNK MAPK mediated Nrf2/ARE pathway.
    Zhang Y; Ahmad KA; Khan FU; Yan S; Ihsan AU; Ding Q
    Chem Biol Interact; 2019 May; 305():54-65. PubMed ID: 30928397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).
    Cheng Z; DiMichele LA; Rojas M; Vaziri C; Mack CP; Taylor JM
    J Mol Cell Cardiol; 2014 Feb; 67():1-11. PubMed ID: 24342076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
    Guo R; Lin J; Xu W; Shen N; Mo L; Zhang C; Feng J
    Int J Mol Med; 2013 Mar; 31(3):644-50. PubMed ID: 23338126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity.
    Zhang X; Zhu JX; Ma ZG; Wu HM; Xu SC; Song P; Kong CY; Yuan YP; Deng W; Tang QZ
    Int J Biol Sci; 2019; 15(3):556-567. PubMed ID: 30745842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes.
    Wang GW; Zhou Z; Klein JB; Kang YJ
    Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2292-9. PubMed ID: 11299233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin-induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways.
    Shati AA
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):660-676. PubMed ID: 31811646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.